Skip to content

CareDx CDNA Current ratio

Current ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.5×-0.2×
Natera, Inc. logo
Natera, Inc.NTRA
-0.9×
NeoGenomics logo
NeoGenomicsNEO
4.4×+2.4×
Personalis, Inc. logo
Personalis, Inc.PSNL
6.6×-0.3×
GeneDx Holdings logo
GeneDx HoldingsWGS
3.1×-0.2×
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
6.7×-2.4×

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from CareDx’s reported figures.

Based on the most recent quarter.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's current ratio?
CareDx (CDNA) reported current ratio of 3.4× in Q1 2026.
How has CareDx's current ratio changed year-over-year?
CareDx's current ratio decreased by 17.1% year-over-year, from 4.1× to 3.4×.
What is the long-term trend for CareDx's current ratio?
Over 5 years (2020 to 2025), CareDx's current ratio has grown at a -6.2% compound annual growth rate (CAGR), from 3.9× to 2.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.